Glooko, a leading provider of remote patient monitoring and digital health solutions for diabetes, has acquired Monarch Medical Technologies, developer of the EndoTool Glucose Management System.

Glooko acquired Monarch Medical Technologies and its EndoTool software, extending the company’s diabetes management platform to hospitals for managing insulin doses within the hospital.

For meaningful progress in the next generation of diabetes technology, innovation must be guided by clinicians and people with diabetes, as highlighted by Glooko Chief Medical and Strategy Officer Mark Clements, M.D., Ph.D.

Glooko CEO Mike Alvarez believes that cybersecurity should be an integral part of the design process for digital health products, not an add-on. For Software as a Medical Device (SaMD) and other digital health technologies, security is crucial for building user trust, ensuring patient safety, and meeting regulatory requirements.

Glooko expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer.

Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.

Glooko announced that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U.S.

Glooko, a digital health company specializing in diabetes management announced the availability of its Patient Portal for Professionals in the Epic Showroom.